Log in to your Inderes Free account to see all free content on this page.
Nanologica
0.39 SEK
+0.51 %
Less than 1K followers
NICA
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Nanologica
EV/S
Median 2019-2024
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (SEK) | 9.94 | 12.70 | 12.98 | 9.48 | 9.86 | 1.80 | 0.77 |
| Shares | 17.6 | 25.2 | 29.7 | 38.1 | 38.1 | 89.1 | 89.1 |
| Market cap | 174.5 | 320.1 | 385.9 | 361.5 | 375.9 | 160.8 | 68.9 |
| Enterprise value | 182.6 | 264.0 | 384.0 | 295.8 | 366.5 | 115.5 | - |
| EV/S | 17.9 | 16.4 | 29.7 | 189.6 | 254.5 | 7.9 | - |
| EV/EBITDA | neg. | neg. | neg. | neg. | neg. | neg. | - |
| EV/EBIT | neg. | neg. | neg. | neg. | neg. | neg. | - |
| P/E | neg. | neg. | neg. | neg. | neg. | neg. | neg. |
| P/B | 42.34 | 3.44 | 7.48 | 4.94 | -197.85 | 2.17 | 3.04 |
| P/S | 17.1 | 19.8 | 29.9 | 231.7 | 261.1 | 11.1 | 3.3 |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 9.7 % | 63.5 % | 52.5 % | 47.3 % | -2.5 % | 51.8 % | 25.7 % |
| Gearing ratio | 221.6 % | 11.0 % | 19.0 % | 6.4 % | -35.3 % | 4.3 % | 221.0 % |
Login required
This content is only available for logged in users